No matter the topic, the 53-year-old leads with a laugh and a really good backstory.
THE WHAT? Novo Nordisk has begun broad US distribution of Wegovy pill, the first oral GLP-1 treatment approved for chronic weight management in adults with obesity or overweight with related medical conditions. THE DETAILS The once-daily oral formulation of semaglutide received FDA approval on December 22, 2025 and is now available through more than…
“I feel more alive and more vibrant than I’ve ever been.”
The wellness platform is reframing the treatment as a preventive health tool, not just a weight-loss solution.
Dermatologists are looking at what else may be at play.
Why timing, skin support and subtlety matter more than volume.
Proof that fast-casual dining is paying attention.